ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: BSX

Boston Scientific to lay off 900 to 1,000 in a bid to save roughly $100 million by year’s end

Boston Scientific to lay off 900 to 1,000 in a bid to save roughly $100 million by year’s end

January 29, 2013 7:44 am by | 0 Comments

In announcing its fourth-quarter earnings Tuesday, Boston Scientific (NYSE:BSX) also announced that it was reducing its workforce by 900 to 1,000 people worldwide, a move that will lower pre-tax operating ... Read more
Lady Luck may shine on Boston Scientific in 2013 if rival’s fortune goes down in flames

Lady Luck may shine on Boston Scientific in 2013 if rival’s fortune goes down in flames

November 26, 2012 12:45 pm by | 0 Comments

It’s not great when a company needs a rival to have a major disaster in order to see the upside, but when you are Boston Scientific (NYSE: BSX), it may ... Read more
BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation

BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation

November 8, 2012 10:53 am by | 0 Comments

 UPDATED WITH ANALYST COMMENTBoston Scientific (NYSE:BSX) is jumping on the renal denervation bandwagon.The Natick, Massachusetts, medical device manufacturer announced Thursday that it is buying Caifornia startup Vessix Vascular for an ... Read more
Analyst: BridgePoint Medical’s acquisition provides “another arrow” in BSX’s cath lab “quiver”

Analyst: BridgePoint Medical’s acquisition provides “another arrow” in BSX’s cath lab “quiver”

September 20, 2012 12:39 pm by | 0 Comments

On Wednesday, after Boston Scientific (NYSE:BSX) announced the acquisition of Minnesota startup BridgePoint Medical, the startup’s CEO said that he is excited by the prospect of having the company’s technology ... Read more
Analyst: Boston Scientific’s reported split of cardiac business underscores failure of integration

Analyst: Boston Scientific’s reported split of cardiac business underscores failure of integration

August 30, 2012 11:08 am by | 0 Comments

If Boston Scientific (NYSE: BSX) were to break up its cardiac rhythm management business into a cardiac unit and an interventional cardiology unit as Reuters reported, the move will spell ... Read more
For Boston Scientific, approval of subcutaneous ICD couldn’t come soon enough

For Boston Scientific, approval of subcutaneous ICD couldn’t come soon enough

July 30, 2012 9:34 am by | 0 Comments

For the last year, Boston Scientific’s(NYSE:BSX) stock has hovered between $5 and $6, and no amount of share buybacks have nudged the price up much.In the company’s second-quarter earnings call ... Read more
Boston Scientific CEO as unsure about bottom of global CRM market as St. Jude

Boston Scientific CEO as unsure about bottom of global CRM market as St. Jude

July 26, 2012 10:05 am by | 0 Comments

If people are looking for confirmation that the global cardiac rhythm management market has declined as much as it could and will fall no further, they have to wait a ... Read more
After St. Jude-Abbott partnership, comes Boston Scientific-Philips deal

After St. Jude-Abbott partnership, comes Boston Scientific-Philips deal

May 14, 2012 4:26 pm by | 0 Comments

Boston Scientific announced Monday that it is collaborating with Royal Philips Electronics through which the Dutch company will sell Boston Scientific Imaging equipment compatible with its imaging systems globally.Specifically, the ... Read more
FDA OKs two Boston Scientific drug-eluting stents for heart attack patients

FDA OKs two Boston Scientific drug-eluting stents for heart attack patients

February 23, 2012 10:54 am by | 0 Comments

 Boston Scientific (NYSE:BSX) announced late Wednesday that the U.S. Food and Drug Administration has approved two drug-coated stent systems for heart attack patients. These are the first stents in the ... Read more
The legacy of Boston Scientific for medtech entrepreneurs

The legacy of Boston Scientific for medtech entrepreneurs

December 15, 2011 6:15 pm by | 1 Comments

A look at how Boston Scientific has shaped the emerging med tech landscape, and where the ex-BSC-ers are making their impact now. ... Read more
Boston Scientific’s Michael Mahoney gets early analyst approval

Boston Scientific’s Michael Mahoney gets early analyst approval

September 14, 2011 6:35 pm by | 0 Comments

Johnson & Johnson’s (NYSE:JNJ) Michael Mahoney will begin leading Boston Scientific (NYSE:BSX) in October, first as president and then begin his tenure at CEO in November. Mahoney joins Boston Scientific ... Read more
BSX’s one-time largest shareholder Paulson & Co. sells all $15M in shares

BSX’s one-time largest shareholder Paulson & Co. sells all $15M in shares

August 17, 2011 3:48 pm by | 0 Comments

Paulson & Co. Inc. is Boston Scientific Corp.’s (NYSE:BSX) largest shareholder no more, after liquidating its position in BSX completely by selling off some 15 million shares of the Natick, ... Read more
Cardiac rhythm management industry still in a slump

Cardiac rhythm management industry still in a slump

August 16, 2011 4:37 pm by | 0 Comments

The cardiac rhythm management industry looks like it needs of a jolt of its own, badly.A look at the earnings releases of two of the big three players in the ... Read more
Boston Scientific takes a beating amid stock market chaos

Boston Scientific takes a beating amid stock market chaos

August 14, 2011 8:47 pm by | 0 Comments

Shares of Boston Scientific Corp. (NYSE:BSX) traded at unusually high volumes for two straight weeks during the recent roller coast on Wall Street, coming in at more than 120 million ... Read more
Boston Scientific to spend $37 million on Irish R&D facility

Boston Scientific to spend $37 million on Irish R&D facility

August 9, 2011 4:44 pm by | 0 Comments

Boston Scientific Corp. (NYSE:BSX) plans to spend $37 million on overseas research and development, this time at its R&D facility in Clonmel, Ireland.The Natick, Mass.-based company hopes to jump-start development ... Read more